PAVmed Inc. ( PAVM) - Key Metrics
PAVM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.86 | -$0.42 | -$0.43 |
| 2026Q1 | $0.01 | -$0.04 | -$1,657.40 | -$1,657.40 |
| 2025Q4 | $0.07 | -$1.63 | -$2 | -$2.02 |
| 2025Q3 | $0.01 | -$7.49 | -$1.25 | -$1.25 |
| 2025Q2 | $0.01 | -$19.78 | -$1.95 | -$1.97 |
PAVM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.71 |
| 2026Q1 | 0% | -0.57 |
| 2025Q4 | 0% | -0.70 |
| 2025Q3 | 0% | -0.37 |
| 2025Q2 | 0% | -0.20 |
PAVM
Price: $2.79
52 week price:
Payout Ratio Range:
Earnings Per Share: -48.31 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 543400
Ebitda: -4.8 millionMarket Capitalization: 17.1 million